State-of-the-Art Research on Diabetic Retinopathy

Rafael Simó

doi:10.3390/jcm11133790

State-of-the-Art Research on Diabetic Retinopathy

J Clin Med. 2022 Jun 30;11(13):3790. doi: 10.3390/jcm11133790.

Author

Rafael Simó^{1

2}

Affiliations

¹ Diabetes and Metabolism Research Unit, Vall d'Hebron Research Institute (VHIR), Autonomous University of Barcelona, Vall d'Hebron Campus, 08035 Barcelona, Spain.
² Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ICSIII), 28029 Madrid, Spain.

Abstract

The scientific community and health care providers should be seriously worried by the fact that diabetic retinopathy (DR) remains the main cause of preventable blindness in the working age population [...].

Publication types

Editorial

Grants and funding

The author has received research grants from the Instituto de Salud Carlos III (ICI20/00129) and Ministerio de Economía y Competitividad (PID2019-104225RB-100).